The purpose of this Decree is to prescribe matters mandated by the Cancer Control Act and matters necessary for the enforcement thereof.
| Article 1-2 (Formulation and implementation of master plans for cancer control) |
| (1) | Upon formulating a master plan for cancer control under Article 5 (1) of the Cancer Control Act (hereinafter referred to as the "Act"), the Minister of Health and Welfare shall publicly announce the details thereof on the website of the Ministry of Health and Welfare and notify the Special Metropolitan City Mayor, a Metropolitan City Mayor, a Special Self-Governing City Mayor, a Do Governor, a Special Self-Governing Province Governor (hereinafter referred to as "Mayor/Do Governor") and the head of a Si/Gun/Gu (referring to the head of an autonomous Gu) thereof. |
| (2) | The Minister of Health and Welfare shall formulate an annual implementation plan to implement a master plan for cancer control under paragraph (1). |
[This Article Added on Apr. 6, 2021]
| Article 2 (Term of office of members of National Cancer Control Commission) |
| (1) | The term of office of members of the National Cancer Control Commission established under Article 6 of the Act (hereinafter referred to as the "Commission") shall be 3 years, and they may be reappointed only once. <Amended on Apr. 6, 2021> |
| (2) | The term of office of a member newly commissioned due to resignation of another commissioned member shall be the remainder of his or her predecessor's term of office. |
| (3) | The Minister of Health and Welfare shall appoint or commission a majority of the members upon recommendation by cancer-related specialized organizations. |
| Article 3 (Operation of Commission) |
| (1) | The chairperson shall represent the Commission and preside over its affairs. |
| (2) | If the chairperson is unable to perform his or her duties due to any unavoidable cause, a member designated by the chairperson shall act on behalf of the chairperson. |
| (3) | A meeting of the Commission shall be called by request of the Minister of Health and Welfare or not less than 1/3 of the members or as deemed necessary by the chairperson, and the chairperson shall chair the meeting. |
| (4) | The meetings of the Commission shall require attendance of the majority of all the incumbent members of the Commission, and the resolution of the meetings shall require consent of the majority of those present. |
| (5) | Except as provided in this Decree, matters necessary for the operation, etc. of the Commission shall be determined by the chairperson following a resolution by the Commission. |
| Article 4 (Executive secretary) |
The Commission shall have an executive secretary to handle its business affairs, who shall be appointed by the Minister of Health and Welfare from among public officials affiliated with the Ministry of Health and Welfare.
| Article 4-2 (Composition and operation of expert committees) |
| (1) | The Commission shall have the following expert committees pursuant to Article 7 (3) of the Act: |
| 1. | The cancer prevention expert committee; |
| 2. | The cancer checkup expert committee; |
| 3. | The cancer patient management expert committee; |
| 4. | The cancer data management expert committee. |
| (2) | A expert committee shall be comprised of up to 10 members, including 1 chairperson, in consideration of gender. |
| (3) | The chairperson of each expert committee shall be elected from among the members of the relevant expert committee, and the members of each expert committee shall be appointed or commissioned by the chairperson of the Commission from among the following persons: |
| 1. | Members of the Commission; |
| 2. | Public officials in charge of cancer prevention and control; |
| 3. | Persons who have extensive expertise and experience in cancer-related fields and are recommended by relevant academic societies, organizations, or members of the Commission. |
| (4) | The term of office of the members of the expert committees commissioned by the chairperson of the Commission shall be 3 years, and they may be reappointed only once. |
| (5) | Meetings of an expert committee shall be convened by the chairperson of the relevant expert committee in any of the following cases: |
| 1. | Where the chairperson of the Commission requests the convocation of a meeting; |
| 2. | Where at least 1/2 of the incumbent members of the relevant expert committee request the convocation of a meeting; |
| 3. | Where the chairperson of the relevant expert committee deems it necessary. |
| (6) | Except as provided in paragraphs (1) through (5), matters necessary for the composition and operation of expert committees shall be determined by the chairperson of the Commission following a resolution by the Commission. |
[This Article Added on Apr. 6, 2021]
Allowances, travel expenses, and other necessary expenses may be paid to members who attend meetings of the Commission and specialized committees within the budget; provided, this shall not apply where a member who is a public official attends a meeting in direct connection to his or her duties. <Amended on Apr. 6, 2021>
| Article 5-2 (Data providers related to cancer data program) |
“Public Institutions prescribed by Presidential Decree” in the former part of Article 9-2 (2) of the Act means the following institutions: | 9. | Seoul National University Dental Hospital established under the Establishment of Seoul National University Dental Hospital Act; |
| 15. | Other institutions deemed necessary by the Minister of Health and Welfare for the cancer data program. |
[This Article Added on Apr. 6, 2021]
| Article 5-3 (Methods and procedures for pseudonymization and combining pseudonymized information) |
| (1) | In any of the following cases, the Minister of Health and Welfare shall have a prior consultation with a data provider under Article 9-2 (2) of the Act on matters necessary for pseudonymization or the combination of pseudonymized information: <Amended on Nov. 8, 2022> |
| 1. | Where requesting data containing personal information pursuant to Article 9-2 (3) of the Act; |
| 2. | Where pseudonymized information is combined and processed pursuant to Article 9-2 (4) of the Act. |
| (2) | A third person who is provided with pseudonymized information from the Minister of Health and Welfare pursuant to Article 9-2 (5) of the Act shall analyze pseudonymized information in a space for which technical, managerial, and physical measures necessary to ensure safety have been implemented (hereafter in this Article referred to as "analyzing space"), as deemed by the Minister of Health and Welfare; provided, where the Minister of Health and Welfare deems that the purpose of analysis cannot be achieved in the analyzing space, the pseudonymized information may be taken out of the analyzing space. |
| (3) | The Minister of Health and Welfare may claim expenses incurred in providing pseudonymized information from a third party to whom pseudonymized information has been provided. |
| (4) | Except as provided in paragraphs (1) through (3), matters necessary for the methods and procedures for pseudonymization and combining pseudonymized information, procedures for providing data, etc. shall be determined and publicly notified by the Minister of Health and Welfare. <Amended on Nov. 8, 2022> |
[This Article Added on Apr. 6, 2021]
[Title Amended on Nov. 8, 2022]
| Article 6 (Scope of cancer checkup program) |
The scope of the cancer checkup program for early detection of cancer under Article 11 (1) of the Act (hereinafter referred to as "the cancer checkup program") shall be as follows: | 1. | Research on standards and quality management of cancer checkups; |
| 2. | Selection and notification of persons subject to cancer checkups within the relevant year (hereinafter referred to as "person scheduled to undergo a cancer checkup") from among those eligible for cancer checkups; |
| 3. | Examination and diagnosis of persons scheduled to undergo cancer checkups; |
| 4. | Subsidies for checkup expenses under Article 11 (4) of the Act; |
| 5. | Education and publicity regarding cancer checkups; |
| 6. | Development and management of information systems for cancer checkups; |
| 7. | Other services deemed necessary by the Minister of Health and Welfare in relation to the cancer checkup program. |
[This Article Wholly Amended on Aug. 20, 2014]
| Article 7 (Persons eligible for cancer checkup program) |
| (1) | Persons eligible for the cancer checkup program under Article 11 (2) of the Act shall be as follows: |
| (2) | “Health insurance policyholders prescribed by Presidential Decree” in Article 11 (4) of the Act means persons determined and publicly notified by the Minister of Health and Welfare based on the amount of monthly insurance premiums, etc. under Article 69 of the National Health Insurance Act. <Amended on Aug. 31, 2012> |
| Article 8 (Types of cancers subject to cancer checkup program and checkup frequencies) |
| (1) | The kinds of cancers subject to the cancer checkup program under Article 11 (2) of the Act shall be as follows: <Amended on May 14, 2019> |
| (2) | The checkup frequencies and age standards for each type of cancer shall be as specified in Appendix 1. |
| Article 9 (Scope of medical expense subsidy program for cancer patients) |
The medical expense subsidy program for cancer patients under Article 13 of the Act shall include the following: <Amended on Aug. 20, 2014> | 1. | Investigation of data on property and income of persons eligible for the medical expense subsidy program; |
| 2. | Selection and notification of persons eligible for the medical expense subsidy program; |
| 3. | Payment of medical expenses to persons eligible for the medical expense subsidy program; |
| 4. | Publicity on the medical expense subsidy program; |
| 5. | Development and management of information systems for the medical expense subsidy program. |
| Article 10 (Persons eligible for subsidization of medical expenses for cancer patients and standards and methods for providing subsidies to cover medical expenses) |
| (1) | Persons eligible for subsidization of medical expenses pursuant to Article 13 (1) of the Act shall be any of the following persons whose income, property, etc. does not exceed the standards determined and publicly notified evert year by the Minister of Health and Welfare (in cases falling under subparagraph 1, including persons obligated to support such persons): <Amended on Apr. 6, 2021> |
| 1. | Cancer patients among children under the Child Welfare Act; provided, if a child who receives subsidies to cover medical expenses reaches the age of 18, the Minister of Health and Welfare may extend the subsidization to cover medical expenses as determined and publicly notified by the Minister of Health and Welfare. |
| 4. | Deleted. <Apr. 6, 2021> |
| (2) | Deleted. <Jul. 26, 2016> |
| (3) | Upon receipt of an application for subsidization of medical expenses under Article 13 (2) of the Act, the head of a health center may request the relevant agency to investigate data on the income, property, etc. of a person eligible for subsidization of medical expenses (in cases falling under paragraph (1) 1, including a person obligated to support him or her). <Amended on Jul. 26, 2016> |
| (4) | If a public official of the competent health center intends to file an application for subsidization of medical expenses on behalf of a cancer patient or a person who acts on behalf of the cancer patient pursuant to Article 13 (3) of the Act, he or she shall receive a written consent with a handwritten signature or name and seal necessary for filing an application for subsidization of medical expenses from the cancer patient or the person who acts on behalf of the cancer patient. <Added on Apr. 6, 2021> |
| (5) | The Minister of Health and Welfare shall determine and publicly notify details, such as the maximum amount of subsidies to cover medical expenses, the period of subsidization, and procedures for payment. <Amended on Apr. 6, 2021> |
| Article 10-2 (Scope of financial information, etc.) |
| (1) | The written consent to be submitted to the head of the competent health center pursuant to Article 13 (4) of the Act shall be affixed with signatures or the names and seals of a cancer patient and his or her household members (referring to the members of an individual household defined in subparagraph 8 of Article 2 of the National Basic Living Security Act; hereinafter the same shall apply). <Amended on Apr. 6, 2021> |
| (2) | “Data or information prescribed by Presidential Decree” in Article 13 (4) 1 of the Act means the data or information classified as follows. <Amended on Apr. 6, 2021> |
| 1. | Demand deposit, such as ordinary deposit, savings deposit, free savings deposit, etc.: Average balance within the last three months; |
| 2. | Savings deposit, such as time deposit, time installment savings, time savings, etc.: Balance or total payments; |
| 4. | Bonds, notes, checks, debt certificates and preemptive right certificates: Face value; |
| 5. | Annuity savings: Amounts paid regularly or final balance; |
| 6. | Interests, dividends, or discounts arising from the financial property under subparagraphs 1 through 5. |
| (3) | “Data or information prescribed by Presidential Decree” in Article 13 (4) 2 of the Act means the following data or information: <Amended on Apr. 6, 2021> |
| 1. | The current status of loans and details of unpaid debts; |
| 2. | The amount of unpaid credit card debts. |
| (4) | “Data or information prescribed by Presidential Decree” in Article 13 (4) 3 of the Act means the data or information classified as follows: <Amended on Apr. 6, 2021> |
| 1. | Insurance policy: Refund to be received if an insurance policy is canceled or the amount of insurance benefits paid within the last one year; |
| 2. | Annuity insurance: Refund to be received if an insurance policy is canceled or the amount to be received on a regular basis. |
[This Article Added on Jul. 26, 2016]
| Article 10-3 (Provision of financial information, etc.) |
| (1) | Upon receipt of a written consent of a cancer patient and his or her household members pursuant to Article 13 (4) of the Act, the head of the competent health center shall submit the consent to the Minister of Health and Welfare through the social security information system under Article 37 (2) of the Framework Act on Social Security (hereinafter referred to as "social security information system"), as determined by the Minister of Health and Welfare. <Amended on Apr. 6, 2021> |
| (2) | Upon receipt of a written consent under paragraph (1), the Minister of Health and Welfare shall, pursuant to Article 13-2 (1) of the Act, request the head of a financial company, etc. under subparagraph 1 of Article 2 of the Act on Real Name Financial Transactions and Confidentiality or the head of a centralized credit information collection agency under Article 25 (2) 1 of the Credit Information Use and Protection Act (hereinafter referred to as "financial institution, etc.") to provide financial information, credit information, and insurance information under Article 13 (4) 1 through 3 of the Act (hereinafter referred to as "financial information, etc.") on cancer patients and their household members, including the following matters: <Amended on Aug. 4, 2020; Apr. 6, 2021> |
| 1. | Names and resident registration numbers of cancer patients and their family members; |
| 2. | Scope of financial information, etc. subject to request for provision, base date for inquiry and inquiry period. |
| (3) | If the head of a financial institution, etc. requested to provide financial information, etc. pursuant to paragraph (2) provides the relevant financial information, etc. to the Minister of Health and Welfare, he or she shall make sure to include the following matters in the financial information, etc. |
| 1. | Names and resident registration numbers of cancer patients and their family members; |
| 2. | Names of financial institutions, etc. providing financial information, etc.; |
| 3. | Names of financial products to be provided and account numbers; |
| 4. | Details of financial information, etc. |
| (4) | The Minister of Health and Welfare may request the heads of financial institutions, etc. to provide financial information, etc. under paragraph (2) through the information and communications networks of associations, federations, or central associations, etc. joined by the relevant financial institutions, etc. |
| (5) | If the Minister of Health and Welfare is provided with financial information, etc. pursuant to paragraph (3) or (4), he or she shall notify the financial information, etc. to the head of the competent health center through a social security information system. |
[This Article Added on Jul. 26, 2016]
| Article 11 (Organization, operation, and duties of epidemiological investigation teams) |
| (1) | In order to conduct an epidemiological investigation under Article 16 (1) of the Act, a central epidemiological investigation team shall be established in the Korea Disease Control and Prevention Agency, and regional epidemiological investigation teams shall be established in the Special Metropolitan City, Metropolitan Cities, Special Self-Governing City, Dos, and Special Self-Governing Province (hereinafter referred to as "City/Do"). <Amended on Sep. 11, 2020; Apr. 6, 2021> |
| (2) | The central epidemiological investigation team shall be comprised of up to 30 members, and a regional epidemiological investigation team shall be comprised of up to 20 members. |
| (3) | The members of the central epidemiological investigation team and a regional epidemiological investigation team (hereinafter referred to as "epidemiological investigation team") shall be appointed or commissioned by the Commissioner of the Korea Disease Control and Prevention Agency in cases of the central epidemiological investigation team and by the Mayor/Do Governor in cases of a regional epidemiological investigation team, from among any of the following persons: <Amended on Sep. 11, 2020; Apr. 6, 2021> |
| 1. | Grade IV or V public officials in charge of the cancer control program or epidemiological investigations; |
| 2. | Experts in epidemiological investigations; |
| 3. | Persons who have medical expertise in cancer; |
| 4. | Experts in environmental and occupational diseases; |
| 6. | Experts in health statistics; |
| 7. | Other experts in medical science or science. |
| (4) | The duties of an epidemiological investigation team shall be as follows: |
| 1. | Formulating epidemiological investigation plans; |
| 2. | Developing the criteria and methods for conducting epidemiological investigations; |
| 3. | Implementing and evaluating epidemiological investigations; |
| 4. | Education and training for the development of epidemiological investigation capabilities; |
| 5. | Collection, analysis, and provision of cancer cases; |
| 6. | Risk assessment of cancer risk factors. |
| (5) | A member who conducts an epidemiological investigation shall carry identification prescribed by Ministerial Decree of Health and Welfare and present it to relevant persons at their request. |
| (6) | The Commissioner of the Korea Disease Control and Prevention Agency and a Mayor/Do Governor may pay allowances, travel expenses, and expenses incurred in conducting epidemiological investigation activities to a person appointed or commissioned as a member of a team within the budget; provided, this shall not apply where a member of a team who is a public official engages in activities in direct connection to his or her business affairs. <Amended on Sep. 11, 2020> |
| (7) | Except as provided in paragraphs (1) through (6), matters necessary for the operation, etc. of an epidemiological investigation team shall be determined by the Commissioner of the Korea Disease Control and Prevention Agency. <Amended on Sep. 11, 2020> |
| Article 12 (Timing, Methods, and Details of Epidemiological Investigations) |
| (1) | Epidemiological Investigations under Article 16 (1) of the Act shall be conducted in accordance with the following classifications: <Amended on Sep. 11, 2020> |
| 1. | Where the central epidemiological investigation team conducts an epidemiological investigation: |
| (a) | Where the epidemiological investigation is to be conducted simultaneously in at least two Cities/Dos; |
| (b) | Where epidemiological investigations by the Mayor/Do Governor are insufficient or where it is impracticable to conduct an epidemiological investigation due to lack of human resources and equipment; |
| (c) | Where an urgent nationwide investigation is required due to the increase in the occurrence of cancer in a specific region and the death resulting from such cancer; |
| (d) | Where the Commissioner of the Korea Disease Control and Prevention Agency deems it necessary to support national cancer control programs and research and to present evidentiary data for policies; |
| 2. | Where a regional epidemiological investigation team conducts an epidemiological investigation: |
| (a) | Based on the cancer registration statistics under Article 14 of the Act, the statistics on causes of death under the Statistics Act, and other specialized medical data, the cancer occurrence rate and the resulting cancer mortality in its jurisdiction are likely to increase, or the cancer occurrence rate and the resulting cancer mortality rate in its jurisdiction is higher than other regions; |
| (b) | If the cancer occurrence rate is likely to increase due to specific hazardous substances and risk factors that may cause cancer (hereinafter referred to as "specific hazardous substances, etc.") in its jurisdiction; |
| (c) | If the Mayor/Do Governor deems it necessary for supporting research necessary for cancer control in its jurisdiction. |
| (2) | When conducting an epidemiological investigation under paragraph (1), the following matters shall be investigated: |
| 1. | The date and place of occurrence, gender, age, and symptoms of cancer patients; |
| 2. | Whether there has been an exposure to specific hazardous substances, etc. and the route of exposure; |
| 3. | The current status of cancer occurrence by age; |
| 4. | Other matters regarding the demographic, economic, and sociological characteristics of the subjects of the investigation. |
| Article 12-2 (Institutions submitting data related to epidemiological investigations) |
“Institutions, organizations, etc. prescribed by Presidential Decree” in the former part of Article 16 (3) of the Act means the following institutions and organizations: | 1. | The Central Cancer Registration Headquarters under Article 17 (1) of the Act and a regional cancer registration headquarters under paragraph (2) of that Article; |
| 2. | The national cancer data center under Article 18-2 of the Act; |
| 3. | A regional cancer center under Article 19 of the Act; |
| 4. | The Nation Korea Cancer Center under Article 27 of the Act; |
[This Article Added on Apr. 6, 2021]
| Article 13 (Grounds for revocation of designation of Central Cancer Registration Headquarters and regional cancer registration headquarters) |
“Grounds prescribed by Presidential Decree” in Article 17 (3) 3 of the Act means any of the following cases: | 1. | Where it fails to conduct an investigation to calculate cancer registration statistics or to submit investigation data; |
| 2. | Where it utilizes cancer registration statistical data for any purpose inconsistent with the purpose under Article 14 (1) of the Act; |
| 3. | Where an institution is relocated to an area other than the designated area. |
| Article 14 Deleted. <Jul. 24, 2017> |
| Article 15 (Organization and faculty of graduate schools) |
| (1) | If the President of the National Cancer Center under Article 33 of the Act (hereinafter referred to as the "President") establishes a graduate school under Article 29 (2) of the Act, he or she shall determine the rules for the graduate school containing the following matters and file a report thereon with the Minister of Health and Welfare: |
| 3. | Matters regarding assets and accounting; |
| 4. | Matters regarding the qualifications and appointment and dismissal of faculty; |
| 5. | Matters regarding the quota, selection, and admission of students; |
| 6. | Matters regarding curricula; |
| 7. | Matters regarding the organization of office and the organization of the graduate school; |
| 8. | Matters regarding public announcement and methods thereof; |
| 9. | Other important matters regarding the operation of the graduate school. |
| (2) | Faculty members of the graduate school shall be appointed from among persons who have expertise and experience in the relevant field, but no faculty member who holds concurrent posts belonging to the National Cancer Center shall be included in the quota of faculty members of the graduate school. |
| Article 16 (Ex officio directors) |
The Vice Minister II of Economy and Finance, the Vice Minister of Education, the Vice Minister of the Interior and Safety, the Vice Minister of Health and Welfare, and the President shall become ex officio directors under Article 31 (2) of the Act. <Amended on Mar. 23, 2013; Nov. 19, 2014; Jul. 26, 2017>
| Article 17 (Duties and remuneration of persons holding concurrent offices) |
| (1) | Pursuant to Article 35 (1) of the Act, a public educational official who concurrently conducts research or medical treatment at a research institute or hospital affiliated with the National Cancer Center (hereinafter referred to as "person holding concurrent offices") shall comply with the articles of incorporation of the National Cancer Center and relevant regulations, and shall conscientiously conduct research or medical treatment at the National Cancer Center. <Amended on Apr. 6, 2021> |
| (3) | The National Cancer Center may pay allowances to persons holding concurrent offices, as prescribed by its articles of incorporation. |
| Article 18 (Dismissal from concurrent offices) |
| (1) | If a person holding concurrent offices violates Article 17 (1) or falls under any subparagraph of Article 78 (1) of the State Public Officials Act, the President shall take measures to dismiss him or her from concurrent offices after deliberation by the personnel committee prescribed by the articles of incorporation. |
| (2) | When the President has taken measures under paragraph (1), he or she shall notify the president or dean of the university to which the person holding concurrent office belongs of such measures. |
| Article 19 (Submission of budget request for contributions) |
The National Cancer Center shall submit to the Minister of Health and Welfare a budget request for contributions for the following year pursuant to Article 37 (2) of the Act, along with the following documents, by April 30 of every business year: <Amended on Jul. 2, 2019> | 1. | A business plan for the following year; |
| 2. | An estimated balance sheet and an estimated income statement for the following year; |
| 3. | Other materials necessary for clarifying the details of the budget request for contributions. |
| Article 20 (Application for payment of contributions) |
If the National Cancer Center intends to receive contributions under Article 37 of the Act, it shall submit to the Minister of Health and Welfare an application for contributions, along with a quarterly budget execution plan.
| Article 21 (Gratuitous lease of State property) |
| (1) | Permission for the gratuitous use of State Property or gratuitous lease of State property under Article 38 (1) of the Act shall be governed by a contract between the head of a central government agency that manages the relevant State property under Article 6 (2) of the National Finance Act and the National Cancer Center. <Amended on Apr. 6, 2021> |
| (2) | The period of permission for the gratuitous use of State property or the period of gratuitous lease of State property under paragraph (1) shall be 5 years, and the period may be renewed. <Amended on Apr. 6, 2021> |
[Title Amended on Apr. 6, 2021]
| Article 22 (Program plan) |
The program plan under Article 40 (1) of the Act shall separately indicate the objectives, policies, major contents of programs, and necessary budgets.
| Article 23 (Submission of statement of settlement of accounts) |
A statement of settlement of accounts under Article 41 of the Act shall be accompanied by the following documents: <Amended Jul. 2, 2019> | 1. | The statement of financial position and the income statement for the relevant year; |
| 2. | A table comparing the business plan for the relevant year with its execution records; |
| 3. | The auditor's audit report and the accounting audit report of a certified public accountant; |
| 4. | Other reference documents verifying the details of the settlement of accounts. |
| Article 24 (Entrustment of business affairs) |
| (1) | Deleted. <Aug. 20, 2014> |
| (2) | Pursuant to Article 50 (2) of the Act, the Minister of Health and Welfare shall entrust the following business affairs to the National Cancer Center: <Amended on Aug. 20, 2014; Jul. 24, 2017; Apr. 6, 2021> |
| 1. | The education and public relations program under Article 4 (2) of the Act; |
| 2. | Development and dissemination of medical treatment methods under Article 10 (1) of the Act; |
| 3. | The cancer prevention program under Article 10-2 of the Act; |
| 4. | The cancer risk factor management program under Article 10-3 of the Act; |
| 5. | Research on standards and quality management of cancer checkups under subparagraph 1 of Article 6; |
| 6. | Development and management of information systems for cancer checkups under subparagraph 6 of Article 6; |
| 7. | Development and management of information systems for the medical expense subsidy program under subparagraph 5 of Article 9. |
| (3) | Pursuant to Article 50 (2) of the Act, the Minister of Health and Welfare shall entrust the National Health Insurance Service established under Article 13 of the National Health Insurance Act with the following business affairs for the cancer checkup program: <Amended on Aug. 31, 2012; Aug. 20, 2014> |
| 1. | Selection and notification of persons scheduled to undergo cancer checkups under subparagraph 2 of Article 6; |
| 2. | Support for subsidy to cover expenses incurred in checkups under subparagraph 4 of Article 6. |
| (4) | Pursuant to Article 50 (2) of the Act, the Minister of Health and Welfare shall entrust the following business affairs to the National Cancer Data Center: <Added on Apr. 6, 2021> |
| 1. | Requesting data under Article 9-2 (2) and (3) of the Act; |
| 2. | Determining the necessity of combining and analyzing pseudonymized information under Article 9-2 (4) of the Act; |
| 3. | Providing pseudonymized information under Article 9-2 (5) of the Act; |
[Title Amended on Aug. 20, 2014]
| Article 24-2 (Processing of sensitive information and personally identifiable information) |
| (1) | The Minister of Health and Welfare (including persons delegated or entrusted with the authority or business affairs of the Minister of Health and Welfare pursuant to Article 24) or the Commissioner of the Korea Disease Control and Prevention Agency may process data containing information on health under Article 23 of the Personal Information Protection Act (limited to cases where he or she performs the business affairs under subparagraphs 1 and 4) and data containing resident registration numbers or alien registration numbers under subparagraph 1 or 4 of Article 19 of the Enforcement Decree of that Act, if it is inevitable for performing the following business affairs: <Amended on Aug. 20, 2014; Jul. 26, 2016; Sep. 11, 2020; Apr. 6, 2021> |
| 1. | Business affairs regarding cancer research programs, etc. under Articles 9, 9-2, 10, 10, 10-2, 10-3, 11, 12, 12, 12-2, 13, 13-2, 14 through 16 of the Act; |
| 2. | Business affairs regarding the designation, revocation of designation, etc. of the Central Cancer Registration Headquarters and a regional cancer registration headquarters under Article 17 of the Act; |
| 3. | Business affairs regarding the designation, revocation of designation, etc. of regional cancer centers under Article 19 of the Act; |
| 4. | Deleted; <Jul. 24, 2017> |
| 5. | Deleted; <Jul. 24, 2017> |
| 6. | Deleted; <Jul. 24, 2017> |
| 7. | Business affairs regarding the appointment of the President of the National Cancer Center, approval of executive officers and employees, etc. under Articles 31, 33, and 34 of the Act. |
| (2) | The State and a local government may process data containing information on health under Article 23 of the Personal Information Protection Act and data containing resident registration numbers or alien registration numbers under subparagraph 1 or 4 of Article 19 of the Enforcement Decree of that Act, where it is inevitable for performing the following business affairs: <Amended on Jul. 26, 2016> |
| 1. | Business affairs regarding subsidies to cover medical expenses incurred by cancer patients under Article 13 of the Act; |
| 2. | Business affairs regarding the request, etc. for financial information, etc. under Article 13-2 of the Act. |
| (3) | The National Cancer Center may process data containing information on health under Article 23 of the Personal Information Protection Act and data containing resident registration numbers or alien registration numbers under subparagraph 1 or 4 of Article 19 of the Enforcement Decree of that Act, where it is inevitable for performing the programs under Article 30 of the Act. <Amended on Aug. 20, 2014> |
[This Article Added on Jan. 6, 2012]
| Article 25 (Criteria for imposing administrative fines) |
The criteria for imposing administrative fines under Article 52 (1) of the Act shall be as specified in Appendix 2.
ADDENDA <Presidential Decree No. 22944, May 30, 2011>
Article 1 (Enforcement date)
This Decree shall enter into force on June 1, 2011.
Article 2 (Repeal of other statutes or regulations)
Article 3 (Transitional measures concerning members of National Cancer Control Commission)
The members of the previous National Cancer Control Commission as at the time this Decree enters into force shall be deemed to have been appointed or commissioned pursuant to the amended provisions of Article 2, and their terms of office shall last until the expiration date of their terms of office under the previous provisions. Article 4 (Transitional measures concerning central epidemiological investigation team and regional epidemiological investigation teams)
A central epidemiological investigation team and regional epidemiological investigation teams established under the previous provisions as at the time this Decree enters into force shall be deemed established under the amended provisions of Article 11.
ADDENDA <Presidential Decree No. 23488, Jan. 6, 2012>
Article 1 (Enforcement date)
This Decree shall enter into force on the date of its promulgation. (Proviso Omitted.)
ADDENDA <Presidential Decree No. 24077, Aug. 31, 2012>
Article 1 (Enforcement date)
This Decree shall enter into force on September 1, 2012. (Proviso Omitted.)
ADDENDA <Presidential Decree No. 24454, Mar. 23, 2013>
Article 1 (Enforcement date)
This Decree shall enter into force on the date of its promulgation. (Proviso Omitted.)
ADDENDUM <Presidential Decree No. 25557, Aug. 20, 2014>
This Decree shall enter into force on the date of its promulgation.
ADDENDA <Presidential Decree No. 25751, Nov. 19, 2014>
Article 1 (Enforcement date)
This Decree shall enter into force on the date of its promulgation; provided, among the Presidential Decrees amended pursuant to Article 5 of these Addenda, the provisions of Presidential Decrees promulgated before this Decree enters into force, but which have not yet entered into force, shall enter into force on the dates the relevant respective Presidential Decrees enter into force.
ADDENDA <Presidential Decree No. 27028, Feb. 29, 2016>
Article 1 (Enforcement date)
This Decree shall enter into force on the date of its promulgation.
Article 2 (Applicability to checkups for hepatoma and cervical cancer)
The amended provisions of Appendix 1 shall begin to apply to checkups conducted after January 1, 2016. In such cases, a checkup for the cervical cancer of women between 20 and 29 years of age as at the time this Decree enters into force shall be conducted according to the following classifications:
| 1. | A cervical cancer checkup in 2016: Women born in even-numbered years; |
| 2. | A cervical cancer checkup in 2017: Women born in odd-numbered years. |
ADDENDUM <Presidential Decree No. 27391, Jul. 26, 2016>
This Decree shall enter into force on August 4, 2016.
ADDENDA <Presidential Decree No. 28206, Jul. 24, 2017>
Article 1 (Enforcement date)
This Decree shall enter into force on August 4, 2017. (Proviso Omitted.)
ADDENDA <Presidential Decree No. 28211, Jul. 26, 2017>
Article 1 (Enforcement date)
This Decree shall enter into force on the date of its promulgation: Provided, That the provisions amending any Decrees that were promulgated before this Decree enters into force but have yet to enter into force, among the Decrees amended pursuant to Article 8 of the Addenda, shall enter into force on the respective dates the relevant Decrees enter into force.
ADDENDUM <Presidential Decree No. 29759, May. 14, 2019>
This Decree shall enter into force on July 1, 2019.
ADDENDUM <Presidential Decree No. 29950, Jul. 2, 2019>
This Decree shall enter into force on the date of its promulgation. (Proviso Omitted.)
ADDENDA <Presidential Decree No. 30893, Aug. 4, 2020>
Article 1 (Enforcement date)
| (1) | This Decree shall enter into force on August 5, 2020. (Proviso Omitted.) |
ADDENDA <Presidential Decree No. 31013, Sep. 11, 2020>
Article 1 (Enforcement date)
This Decree shall enter into force on September 12, 2020.
ADDENDUM <Presidential Decree No. 31604, Apr. 6, 2021>
This Decree shall enter into force on April 8, 2021; provided, the amended provisions of Article 10 (1) shall enter into force on July 1, 2021.
ADDENDUM <Presidential Decree No. 32982, Nov. 8, 2022>
This Decree shall enter into force on the date of its promulgation.